Diagnostic yield of genetic tests in epilepsy

To compare the cost-effectiveness of genetic testing strategies in patients with epilepsy of unknown etiology.This meta-analysis and cost-effectiveness study compared strategies involving 3 genetic tests: chromosomal microarray (CMA), epilepsy panel (EP) with deletion/duplication testing, and whole-exome sequencing (WES) in a cost-effectiveness model, using "no genetic testing" as a point of comparison.Twenty studies provided information on the...